We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$22.4B
AUM Growth
+$2.11B
Cap. Flow
+$775M
Cap. Flow %
3.46%
Top 10 Hldgs %
20.85%
Holding
3,349
New
266
Increased
1,598
Reduced
1,206
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 10.23%
2 Consumer Discretionary 4.98%
3 Financials 4.7%
4 Healthcare 3.82%
5 Communication Services 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIL
3126
DELISTED
Hill International, Inc. Common Stock
HIL
$20K ﹤0.01%
10,000
PSFE.WS
3127
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$19K ﹤0.01%
28,500
+18,000
+171% +$22.6K
VERO
3128
DELISTED
Venus Concept
VERO
$19K ﹤0.01%
68
CNSP icon
3129
CNS Pharmaceuticals
CNSP
$7.53M
0
SBEAW
3130
DELISTED
SilverBox Engaged Merger Corp I Warrant
SBEAW
$17K ﹤0.01%
+12,000
New +$17.1K
RAVE icon
3131
RAVE Restaurant Group
RAVE
$44.2M
$16K ﹤0.01%
15,499
SMTS
3132
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$16K ﹤0.01%
11,621
-3,847
-25% -$6.64K
XPL icon
3133
Solitario Resources
XPL
$73.9M
$15K ﹤0.01%
29,761
-1,004
-3% -$518
TRX icon
3134
TRX Gold Corp
TRX
$341M
$14K ﹤0.01%
36,300
+16,300
+82% +$7.06K
FEED
3135
ENvue Medical Inc
FEED
$3.54M
$13K ﹤0.01%
+6
New +$17.8K
NXTP
3136
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$13K ﹤0.01%
750
WTER
3137
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$13K ﹤0.01%
+727
New +$15.8K
NAK
3138
Northern Dynasty Minerals
NAK
$930M
$11K ﹤0.01%
33,100
NERV icon
3139
Minerva Neurosciences
NERV
$187M
$11K ﹤0.01%
1,738
-187
-10% -$1.76K
TLPH icon
3140
Talphera
TLPH
$62.8M
$10K ﹤0.01%
909
-300
-25% -$4.56K
TTOO
3141
DELISTED
T2 Biosystems, Inc
TTOO
$10K ﹤0.01%
4
HEXO
3142
DELISTED
HEXO Corp. Common Shares
HEXO
$10K ﹤0.01%
1,073
+47
+5% +$873
NBEV
3143
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$10K ﹤0.01%
10,000
-1,290
-11% -$1.7K
BTAQW
3144
DELISTED
Burgundy Technology Acquisition Corporation Warrant
BTAQW
$10K ﹤0.01%
+17,000
New +$12.4K
TYME
3145
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$8K ﹤0.01%
14,000
CRVO icon
3146
CervoMed
CRVO
$39.6M
$6K ﹤0.01%
277
TXMD icon
3147
TherapeuticsMD
TXMD
$24.1M
$6K ﹤0.01%
340
+32
+10% +$959
NEPT
3148
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$5K ﹤0.01%
9
-3
-25% -$2.06K
GPL
3149
DELISTED
Great Panther Mining Limited
GPL
$5K ﹤0.01%
2,378
+100
+4% +$340
PULM icon
3150
Pulmatrix
PULM
$5.51M
$4K ﹤0.01%
510

Similar funds

Cambridge Investment Research Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Cambridge Investment Research Advisors held 3,349 positions worth $22.4B, up 10% from $20.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $775M of net new capital in Q4 2021, opening 266 new positions and adding to 1,598 existing holdings. Its largest new stake was CION Investment: 424,367 shares worth $5.55M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $19.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2021 buy was CION Investment: 424,367 shares worth $5.55M.
  • Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q4 2021, an estimated $88.6M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $19.5M.
  • Cambridge Investment Research Advisors fully exited VEREIT, Inc. in Q4 2021, selling an estimated $5.14M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $22.4B portfolio in Q4 2021.
  • Cambridge Investment Research Advisors opened 266 new positions and closed 184 in Q4 2021.
  • Cambridge Investment Research Advisors's portfolio value rose 10% quarter-over-quarter to $22.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.